Vastox Acquires DanioLabs

Vastox PLC (AIM: VOX) has acquired DanioLabs Ltd., a UK-based drug company focused on neuro disorders. The deal is valued at Gbp15 million, including Gbp159,000 in cash and around 11.73 million ordinary Vastox shares. DanioLabs had raised venture funding from Gateway Global. www.vastox.com